1. Home
  2. NAKA vs ALDX Comparison

NAKA vs ALDX Comparison

Compare NAKA & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAKA
  • ALDX
  • Stock Information
  • Founded
  • NAKA 2019
  • ALDX 2004
  • Country
  • NAKA United States
  • ALDX United States
  • Employees
  • NAKA N/A
  • ALDX N/A
  • Industry
  • NAKA
  • ALDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAKA
  • ALDX Health Care
  • Exchange
  • NAKA Nasdaq
  • ALDX Nasdaq
  • Market Cap
  • NAKA 347.4M
  • ALDX 296.0M
  • IPO Year
  • NAKA 2024
  • ALDX 2014
  • Fundamental
  • Price
  • NAKA $0.49
  • ALDX $4.76
  • Analyst Decision
  • NAKA Strong Buy
  • ALDX Strong Buy
  • Analyst Count
  • NAKA 2
  • ALDX 2
  • Target Price
  • NAKA $5.00
  • ALDX $9.50
  • AVG Volume (30 Days)
  • NAKA 28.5M
  • ALDX 631.0K
  • Earning Date
  • NAKA 11-05-2025
  • ALDX 11-05-2025
  • Dividend Yield
  • NAKA N/A
  • ALDX N/A
  • EPS Growth
  • NAKA N/A
  • ALDX N/A
  • EPS
  • NAKA N/A
  • ALDX N/A
  • Revenue
  • NAKA $2,239,936.00
  • ALDX N/A
  • Revenue This Year
  • NAKA N/A
  • ALDX N/A
  • Revenue Next Year
  • NAKA $2,755.19
  • ALDX $63.48
  • P/E Ratio
  • NAKA N/A
  • ALDX N/A
  • Revenue Growth
  • NAKA N/A
  • ALDX N/A
  • 52 Week Low
  • NAKA $0.52
  • ALDX $1.14
  • 52 Week High
  • NAKA $34.77
  • ALDX $7.20
  • Technical
  • Relative Strength Index (RSI)
  • NAKA 28.22
  • ALDX 40.19
  • Support Level
  • NAKA $0.53
  • ALDX $4.73
  • Resistance Level
  • NAKA $0.98
  • ALDX $5.35
  • Average True Range (ATR)
  • NAKA 0.07
  • ALDX 0.26
  • MACD
  • NAKA 0.05
  • ALDX -0.02
  • Stochastic Oscillator
  • NAKA 4.32
  • ALDX 29.70

About NAKA Kindly MD Inc. Common Stock

Kindly MD Inc is a holistically focused pain management clinic and healthcare data company. It offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Its specialty outpatient clinical services are offered on a subscription and fee-for-service basis to augment traditional healthcare. The Company offers evaluation and management, including, but not limited to chronic pain, functional medicine, cognitive behavioral therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy.

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

Share on Social Networks: